Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-07-29

Clinical Trial Update: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/Phase 2 clinical trial evaluating bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for acute respiratory distress syndrome h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bone marrow mesenchymal stem cell-derived extracellular vesicles infusion

Snippet

Sponsor: Direct Biologics, LLC | Conditions: ARDS, Human | Phase 1, Phase 2 | Status: WITHDRAWN